Abstract: In one example, a computer implemented method may include designating a configurable object as a guarded object to restrict access to the configurable object. Further, the method may include receiving a request to access the guarded object and determining whether the request is received from a user having a privilege to access the guarded object. Furthermore, the method may include controlling the access to the guarded object based on the determination.

Abstract: An example method of deploying a logical network platform in a virtualized computing system, the virtualized computing system including a host cluster and a virtualization management server connected to a physical network, the host cluster having hosts and a virtualization layer executing on hardware platforms of the hosts is described. The method includes receiving, at the virtualization management server, a declarative specification describing a proposed state of the logical network platform; deploying, by the virtualization management server, a network manager of the logical network platform in response to the proposed state in the declarative specification; and deploying, by the virtualization management server in cooperation with the network manager, binaries to the hosts in the host cluster.

Abstract: A system, method, and computer program product for generating healthcare data keyword files is disclosed. The system may include a reader module on a computer, a mapper module on a computer, and a generator module on a computer. The reader module may be configured to read one or more healthcare data fields associated with a first vendor and read one or more portions of healthcare data associated with the one or more data fields. The mapper module may be configured to allow a first mapping of the one or more data fields to one or more keyword fields. In accordance with the first mapping, the generator module may be configured to generate one or more keywords associated with the one or more portions of healthcare data.

Abstract: A system, method, and computer program product for generating healthcare data keyword files is disclosed. The system may include a reader module on a computer, a mapper module on a computer, and a generator module on a computer. The reader module may be configured to read one or more healthcare data fields associated with a first vendor and read one or more portions of healthcare data associated with the one or more data fields. The mapper module may be configured to allow a first mapping of the one or more data fields to one or more keyword fields. In accordance with the first mapping, the generator module may be configured to generate one or more keywords associated with the one or more portions of healthcare data.

Abstract: Provided are muscarinic receptor antagonists, which can be useful in treating various diseases of the respiratory, urinary or gastrointestinal system mediated through muscarinic receptors. Also provided are processes for preparing compounds described herein, pharmaceutical compositions comprising compounds described herein, and methods for treating diseases mediated through muscarinic receptors.

Abstract: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.

Abstract: This invention relates to combination therapy for the treatment of lower urinary tract symptoms (LUTS) associated with or without benign prostatic hyperplasia (BPH). The combination therapy comprises of tailored 1 adrenoceptor antagonist, which is selective for 1a over 1b subtype but non-selective for 1a over 1d subtype, in combination with muscarinic receptor antagonist, preferably bladder selective antagonist and optionally included 5-reductase inhibitor for relief of LUTS in a mammal with or without BPH.